Relaxation induced by cGMP phosphodiesterase inhibitors sildenafil and zaprinast in human vessels

Annals of Thoracic Surgery

Volumn 70, Issue 4, 2000, Pages 1327-1331

  Medina, Pascual ^a   Segarra, Gloria ^a   Martínez León, Juan B ^a   Vila, José M ^a   Aldasoro, Martín ^a   Otero, Eduardo ^a   Lluch, Salvador ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP PHOSPHODIESTERASE; ENZYME INHIBITOR; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; SILDENAFIL; ZAPRINAST;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY CONSTRICTION; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN TISSUE; HYPOTENSION; INTERNAL MAMMARY ARTERY; MALE; MUSCLE ISOMETRIC CONTRACTION; ORGAN DONOR; PRIORITY JOURNAL; RADIAL ARTERY; SMOOTH MUSCLE RELAXATION; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; COMPARATIVE STUDY; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; MAMMARY ARTERIES; MUSCLE, SMOOTH, VASCULAR; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINONES; RADIAL ARTERY; SUPPORT, NON-U.S. GOV'T; VASODILATION; VEINS;

EID: 0033783133     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01914-7     Document Type: Article

References (23)

1. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
2. Effects of sildenafil, a type 5 cyclic GMP phosphodiesterase inhibitor on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro
3. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes
4. Sildenafil, a novel oral therapy for male erectile dysfunction
5. Oral sildenafil in the treatment of erectile dysfunction
6. Sildenafil, a type-5 cGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro
7. Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study
8. Does severity of ischemic disease correlate with erectile function?
9. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease
10. Effects of sildenafil citrate on human hemodynamics
11. Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates
12. Cyclic guanosine monophosphate as a mediator of vasodilation
13. Effects of sildenafil on human penile blood vessels
14. Primary sequence of cyclic nucleotide phospodiesterase enzymes and the design of selective inhibitors
15. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro
16. Intracellular cyclic GMP receptor proteins
17. Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase
18. Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta
19. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
20. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
21. Sildenafil citrate and blood-pressure-lowering drugs: Results of drug interaction studies with an organic nitrate and a calcium antagonist
22. Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee
23. Clinical pharmacology, physiology and pathophysiology of superficial veins-1